65505-76-2

Basic information

• Product Name: 5-chloromercurio-2-'-deoxyuridine
• Synonyms: 5-chloromercurio-2-'-deoxyuridine
• CAS NO: 65505-76-2
• Molecular Formula: C₉H₁₁ClHgN₂O₅
• Molecular Weight: 0
• Mol File: 65505-76-2.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 5-chloromercurio-2-'-deoxyuridine(CAS DataBase Reference)
• NIST Chemistry Reference: 5-chloromercurio-2-'-deoxyuridine(65505-76-2)
• EPA Substance Registry System: 5-chloromercurio-2-'-deoxyuridine(65505-76-2)

Safety Data

• Hazardous Substances Data: 65505-76-2(Hazardous Substances Data)

Upstream product

• 1600-27-7 mercury(II) diacetate 
• 951-78-0 2'-deoxyuridine 
• 951-78-0 2'-deoxyuridine 

Downstream Products

• 15761-83-8 5-phenyluracil 
• 76756-28-0 1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-phenylpyrimidine-2,4(1H,3H)-dione 
• 69819-96-1 5-(3,3,3-trifluoro-1-propenyl)-2'-deoxyuridine 
• 87985-53-3 5-<3,3,3-trifluoro-1-(propoxy)propyl>-2'-deoxyuridine 
• 951-78-0 2'-deoxyuridine 
• 100634-97-7 5-phenylsulfanyl-2'-deoxyuridine 
• 115794-55-3 5-(3''-trifluoroacetamidoallyl)-2'-deoxyuridine 
• 54-42-2 5-Iodo-2'-deoxyuridine 
• 73847-55-9 5-<2-(3-aminophenyl)ethyl>-2'-deoxyuridine hydrochloride 
• 73847-54-8 5(E)-(3-aminostyryl)-2'-deoxyuridine 
• 73847-52-6 5-(2-phenylethyl)-2'-deoxyuridine 
• 66270-29-9 (E)-5-(1-propenyl)-2'-deoxyuridine 
• 187245-29-0 Thiobenzoic acid S-[2-(1-{(2R,4S,5R)-5-[bis-(4-methoxy-phenyl)-phenyl-methoxymethyl]-4-hydroxy-tetrahydro-furan-2-yl}-2,4-dioxo-1,2,3,4-tetrahydro-pyrimidin-5-yl)-ethyl] ester 
• 187245-17-6 Thiobenzoic acid S-(2-{1-[(2R,4S,5R)-4-(tert-butyl-dimethyl-silanyloxy)-5-(tert-butyl-dimethyl-silanyloxymethyl)-tetrahydro-furan-2-yl]-2,4-dioxo-1,2,3,4-tetrahydro-pyrimidin-5-yl}-ethyl) ester 

Relevant articles and documents

A SYSTEM FOR DELIVERING THERAPEUTIC AGENTS INTO LIVING CELLS AND CELL NUCLEI

A novel class of oligomeric compounds designed for forming conjugates with biologically active substances and delivering these substances to a desired bodily target are disclosed. Nove1 conjugates of biologically active moities and such oligomeric compounds, pharmaceutical compositions containing such conjugates, and uses thereof as delivery systems for delivering the biologically active substances to a desired target are further disclosed. Processes of preparing the conjugates and the oligomeric compounds and novel intermediates designed for and used in these processes are also disclosed.

Method of making radioiodinated pyrimidine nucleoside or nucleotide

The method of making radioiodinated pyrimidine nucleoside or nucleotide which comprises contacting a water-insoluble halomercuri pyrimidine nucleoside or nucleotide with an aqueous medium containing a dissolved radioactive iodide ion and an oxidizing agent, the molar amounts of said nucleoside or nucleotide and said oxidizing agent being in excess of the molar amount of said iodide, whereby water-soluble radioactive iodinated pyrimidine nucleoside or nucleotide is formed in solution, and separating residual water-insoluble halomercuri pyrimidine nucleoside or nucleotide from said solution.